118 related articles for article (PubMed ID: 7980901)
1. Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal model.
Lofgren LA; Ronn AM; Abramson AL; Shikowitz MJ; Nouri M; Lee CJ; Batti J; Steinberg BM
Arch Otolaryngol Head Neck Surg; 1994 Dec; 120(12):1355-62. PubMed ID: 7980901
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
Savary JF; Monnier P; Fontolliet C; Mizeret J; Wagnières G; Braichotte D; van den Bergh H
Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
[TBL] [Abstract][Full Text] [Related]
3. Determination of the maximal tumor/normal skin ratio after HpD or m-THPC administration in hairless mouse (SKh-1) by fluorescence spectroscopy--a non-invasive method.
Bossu E; A'Amar O; Parache RM; Notter D; Labrude P; Vigneron C; Guillemin F
Anticancer Drugs; 1997 Jan; 8(1):67-72. PubMed ID: 9147614
[TBL] [Abstract][Full Text] [Related]
4. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Peng Q; Moan J; Ma LW; Nesland JM
Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis.
Shikowitz MJ; Abramson AL; Steinberg BM; DeVoti J; Bonagura VR; Mullooly V; Nouri M; Ronn AM; Inglis A; McClay J; Freeman K
Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):99-105. PubMed ID: 15723939
[TBL] [Abstract][Full Text] [Related]
6. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
[TBL] [Abstract][Full Text] [Related]
7. Hematoporphyrin derivative therapy of papillomas. Experimental study.
Shikowitz MJ; Steinberg BM; Abramson AL
Arch Otolaryngol Head Neck Surg; 1986 Jan; 112(1):42-6. PubMed ID: 3000329
[TBL] [Abstract][Full Text] [Related]
8. Interstitial photodynamic therapy with tetra(m-hydroxyphenyl)chlorin: tumor versus striated muscle damage.
Andrejevic-Blant S; Woodtli A; Wagnieres G; Fontolliet C; van den Bergh H; Monnier P
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):403-12. PubMed ID: 9788423
[TBL] [Abstract][Full Text] [Related]
9. Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy.
Bossu E; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F
Anticancer Drugs; 2000 Feb; 11(2):85-91. PubMed ID: 10789590
[TBL] [Abstract][Full Text] [Related]
10. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system.
Lee RG; Vecchiotti MA; Heaphy J; Panneerselvam A; Schluchter MD; Oleinick NL; Lavertu P; Alagramam KN; Arnold JE; Sprecher RC
Laryngoscope; 2010 Mar; 120(3):618-24. PubMed ID: 20091778
[TBL] [Abstract][Full Text] [Related]
12. Histological and molecular analysis of cottontail rabbit papillomavirus-induced papillomas treated with hematoporphyrin derivative photodynamic therapy.
Shikowitz MJ; Steinberg BM; Galli RL; Abramson AL
Arch Otolaryngol Head Neck Surg; 1988 Feb; 114(2):175-8. PubMed ID: 2827705
[TBL] [Abstract][Full Text] [Related]
13. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.
Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P
Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer.
Abulafi AM; DeJode ML; Allardice JT; Ansell JK; Williams NS
Br J Surg; 1997 Mar; 84(3):368-71. PubMed ID: 9117310
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer.
Wyss P; Schwarz V; Dobler-Girdziunaite D; Hornung R; Walt H; Degen A; Fehr M
Int J Cancer; 2001 Sep; 93(5):720-4. PubMed ID: 11477585
[TBL] [Abstract][Full Text] [Related]
17. PEG-m-THPC-mediated photodynamic effects on normal rat tissues.
Hornung R; Fehr MK; Walt H; Wyss P; Berns MW; Tadir Y
Photochem Photobiol; 2000 Nov; 72(5):696-700. PubMed ID: 11107857
[TBL] [Abstract][Full Text] [Related]
18. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
Chang SC; Buonaccorsi G; MacRobert A; Bown SG
Int J Cancer; 1996 Aug; 67(4):555-62. PubMed ID: 8759616
[TBL] [Abstract][Full Text] [Related]
19. In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
Blant SA; Woodtli A; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Photochem Photobiol; 1996 Dec; 64(6):963-8. PubMed ID: 8972639
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
